The Long Run with Luke Timmerman

A podcast by Timmerman Report

173 Episodes

  1. Ep135: John Maraganore on Developing a New Class of Medicines

    Published: 5/8/2023
  2. Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies

    Published: 4/24/2023
  3. Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies

    Published: 4/12/2023
  4. Ep132: Eric Dobmeier on Treating Kidney Disease

    Published: 3/28/2023
  5. Ep131: Ryan Watts on Neuroscience Drug R&D

    Published: 3/14/2023
  6. Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave

    Published: 2/28/2023
  7. Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

    Published: 2/14/2023
  8. Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last

    Published: 2/1/2023
  9. Ep127: Jeb Keiper on Computational Drug Discovery

    Published: 1/20/2023
  10. Ep126: DA Wallach on Becoming a Biotech VC

    Published: 1/3/2023
  11. Ep125: Barry Greene on a New Drug for Depression

    Published: 12/19/2022
  12. Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines

    Published: 11/8/2022
  13. Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery

    Published: 10/27/2022
  14. Ep122: Aetna Wun Trombley on Extracellular Protein Degraders

    Published: 10/11/2022
  15. Ep121: Samantha Truex on Going Upstream Against Severe Asthma

    Published: 9/26/2022
  16. Ep120: Tim Lu on Gene Circuits for Cell Therapy

    Published: 9/7/2022
  17. Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease

    Published: 8/22/2022
  18. Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes

    Published: 8/8/2022
  19. Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World

    Published: 7/11/2022
  20. Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience

    Published: 6/22/2022

3 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.